Title: An interview with Dr. Heiko Hermeking on his highly cited paper published in<i>Cell Cycle</i>
Abstract:Heiko Hermeking holds a professorship for Experimental and Molecular Pathology at the Pathology Institute of the Ludwig-Maximilians University Munich in Germany. He also received his Ph.D. from this u...Heiko Hermeking holds a professorship for Experimental and Molecular Pathology at the Pathology Institute of the Ludwig-Maximilians University Munich in Germany. He also received his Ph.D. from this university, working in Dirk Eick’s laboratory, where he discovered that p53 mediates c-MYC-induced apoptosis. He then carried out four years of postdoctoral studies in Bert Vogelstein and Ken Kinzler’s laboratory at the Johns Hopkins Medical School in Baltimore, MD, where he used the SAGE technique, which had just been developed in this laboratory, to identify important p53 (14-3-3 ) and c-MYC (CDK4) target genes. Then he was an independent group leader at the Max-Planck-Institute of Biochemistry in Martinsried near Munich. His current work focuses on the analysis of genes, microRNAs and pathways that are regulated by c-MYC or p53.Read More